Company / Operating Income
Krystal Biotech, Inc. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$161.3M
FY2025
5-year range
-$145.2M / $161.3M
FY2021-FY2025
Trend
+145.3%
vs FY2024
Sector context
#30 of 204
Health Care
What the data says
Krystal Biotech, Inc.'s operating income of $161M is higher than 85% of companies in the Health Care sector (FY2025). Operating Income has increased for 3 consecutive years, from -$145M in FY2022 to $161M in FY2025.
Based on SEC 10-K filings.
$161M in FY2025. Top quartile in the Health Care sector.
Improved from -$110M to $161M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 204This company $161.3M Sector average $107.7M
▼
+49.7% above sector average
Key checks
Key Insights
- Krystal Biotech, Inc.'s operating income has grown for 3 consecutive years.
- In FY2025, operating income increased 145.3% year-over-year.
- Ranks #30 out of 204 companies in the Health Care sector.
- Lowest operating income in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 5.66 (safe zone, above 2.9 threshold)
- Strong profit margin: 30.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $161.3M | +145.3% |
| FY2024 | $65.7M | +160.0% |
| FY2023 | -$109.6M | +24.5% |
| FY2022 | -$145.2M | -112.7% |
| FY2021 | -$68.3M | -106.9% |
| FY2020 | -$33.0M | -49.4% |
| FY2019 | -$22.1M | -85.3% |
| FY2018 | -$11.9M | -149.7% |
| FY2017 | -$4.8M | -317.5% |
| FY2016 | -$1.1M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026